Name | (4R)-4-[(3R,5R,8R,9S,10S,12S,13R,14S,17R)-3,12-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid |
---|---|
Synonyms |
Cholan-24-oic-24-C acid, 3,12-dihydroxy-, (3α,5β,12α)-
3a,12a-Dihydroxy-5|A-cholanic acid-24-13C Cholan-24-oic-24-C acid, 3,12-dihydroxy-, (3α,5β,12β)- 7-Deoxycholic acid-24-13C (3α,5β,12β)-3,12-Dihydroxy(24-C)cholan-24-oic acid <24-13C>-Deoxycholsaeure Deoxycholic acid-24-13C Desoxycholic acid-24-13C (3α,5β,12α)-3,12-Dihydroxy(24-C)cholan-24-oic acid 3a,12a-Dihydroxy-5ß-cholanic acid-24-13C,7-Deoxycholic acid-24-13C,Desoxycholic acid-24-13C |
Description | Deoxycholic acid-13C (Cholanoic acid-13C) is the 13C-labeled Deoxycholic acid. Deoxycholic acid is specifically responsible for activating the G protein-coupled bile acid receptor TGR5 that stimulates brown adipose tissue (BAT) thermogenic activity. |
---|---|
Related Catalog | |
In Vitro | Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1]. |
References |
Density | 1.1±0.1 g/cm3 |
---|---|
Molecular Formula | C24H40O4 |
Molecular Weight | 393.565 |
Exact Mass | 393.296021 |
PSA | 77.76000 |
LogP | 4.47790 |
Index of Refraction | 1.543 |
Symbol |
GHS07 |
---|---|
Signal Word | Warning |
Hazard Statements | H302-H315-H319-H335 |
Precautionary Statements | P261-P305 + P351 + P338 |
Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Faceshields;Gloves |
RIDADR | NONH for all modes of transport |